Hana

Hana is a prescription oral tablet containing the progestogen desogestrel, marketed in the European Union. Each tablet delivers a standard dose of desogestrel (strength not specified) and is intended for use as a progestin‑only hormonal contraceptive. The medication works by selectively binding progesterone receptors to inhibit ovulation and modify cervical mucus, providing reliable daily birth control for women seeking a single‑component regimen throughout the menstrual cycle.

Hana is indicated for contraception as a progestin‑only oral contraceptive.

- Prevention of pregnancy in women who require a single‑component hormonal method. - Use in women who are breastfeeding or cannot take estrogen‑containing contraceptives. - Suitable for women seeking a daily oral regimen with a predictable dosing schedule. - May be prescribed for menstrual cycle regulation when hormonal contraception is desired. - Can be used as a backup method for up to 48 hours after missed dose, following physician guidance. - Appropriate for women with contraindications to estrogen, such as a history of thromboembolic events.

Side effects reported with Hana can vary in frequency and severity.

Common: - Irregular menstrual bleeding or spotting, which may include prolonged bleeding, breakthrough bleeding, or missed periods. - Headache, ranging from mild tension-type to moderate intensity. - Nausea or mild gastrointestinal discomfort, such as abdominal cramping or bloating. - Breast tenderness or mild swelling, often occurring during the initial weeks of therapy.

Serious: - Deep vein thrombosis or pulmonary embolism, presenting as leg pain, swelling, or shortness of breath and requiring immediate medical attention. - Severe allergic reaction such as rash, swelling of the face or throat, or difficulty breathing, which should be treated as an emergency.

Precautions should be considered before starting Hana to ensure safe and effective use.

- Women with a history of thromboembolic disorders should discuss alternative contraception with their healthcare provider. - Current or past breast cancer, liver disease, or hormone‑sensitive tumors require medical evaluation prior to use. - Smoking more than 15 cigarettes per day, especially in women over 35, increases cardiovascular risk. - Use of other hormonal therapies or certain antibiotics may affect the efficacy of desogestrel. - If a dose is missed for more than 12 hours, follow the prescribed backup instructions to maintain contraceptive protection.

Hana may interact with other medicines, affecting its contraceptive effectiveness or safety profile.

Avoid: - Concurrent use of enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) that markedly reduce desogestrel levels. - Combined use with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) that may increase hormone concentrations and risk of side effects.

Use with caution: - Rifampin or other strong inducers may decrease effectiveness; additional non‑hormonal contraception may be needed. - Certain antibiotics (e.g., clarithromycin) may have a moderate effect; monitor for breakthrough bleeding. - Herbal supplements such as St. John’s wort can lower hormone levels; discuss with a healthcare professional. - Antifungal agents like fluconazole may increase desogestrel concentrations; observe for signs of hormonal excess.